world-economy
FW Desk News
FreightWatch.News
Sunday, July 26, 2026
India has successfully positioned itself in a reduced tariff category through ongoing negotiations with the Trump administration, gaining a competitive advantage for its key exports. The move comes as the U.S. implements sweeping duties across multiple trading partners, with China, Mexico and Canada facing the heaviest burden at 99.4% of their imports subject to new levies. The administration has structured a tiered tariff approach, with India landing in a lower classification than many trading partners. Australia and the European Union have objected to the tariff regime, citing concerns over forced labor allegations used to justify the duties. Separately, the administration outlined a 200% tariff on generic pharmaceuticals with a two-year grace period before rates escalate further. The varied tariff structure signals the White House's strategy to reward cooperative trade partners while penalizing others.